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Abstract
The epidemiology and bacteriology of urinary tract infection (UTI) varies across the human lifespan, but the reasons for
these differences are poorly understood. Using established monomicrobial and polymicrobial murine UTI models caused by
uropathogenic Escherichia coli (UPEC) and/or Group B Streptococcus (GBS), we demonstrate age and parity as inter-related
factors contributing to UTI susceptibility. Young nulliparous animals exhibited 10–100-fold higher bacterial titers compared
to older animals. In contrast, multiparity was associated with more severe acute cystitis in older animals compared to age-
matched nulliparous controls, particularly in the context of polymicrobial infection where UPEC titers were ,1000-fold
higher in the multiparous compared to the nulliparous host. Multiparity was also associated with significantly increased risk
of chronic high titer UPEC cystitis and ascending pyelonephritis. Further evidence is provided that the increased UPEC load
in multiparous animals required TLR4-signaling. Together, these data strongly suggest that the experience of childbearing
fundamentally and permanently changes the urinary tract and its response to pathogens in a manner that increases
susceptibility to severe UTI. Moreover, this murine model provides a system for dissecting these and other lifespan-
associated risk factors contributing to severe UTI in at-risk groups.
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Introduction
Urinary tract infection (UTI) is one of the most common
bacterial infections in humans, with an estimated annual incidence
rate of nearly 13% in women [1]. Approximately 8 million
outpatient visits occur each year due to UTI, costing an estimated
$2 billion in annual health care costs in the United States [2].
Uncomplicated UTI are most often caused by uropathogenic
Escherichia coli (UPEC). Complicated UTI is associated with
functional or structural urinary tract abnormalities, pregnancy,
or urinary catheterization. These host factors are associated with
increased rates of infection with a more diverse array of organisms,
including Streptococcus agalactiae (Group B Streptococcus, GBS). GBS
commonly colonizes the same anatomical niches (urogenital tract,
gut) as UPEC, is adept at causing infections in a variety of human
tissues including the urinary tract, and has immune modulatory
capabilities [3,4,5].
Physical, hormonal, and immunological changes that occur
throughout the female lifespan are thought to put women at
additional risk of bladder infection (cystitis), as well as ascending
kidney (pyelonephritis) and disseminated (bloodstream) infections
[6,7,8,9]. For example, a number of studies show that asymptom-
atic bacteriuria (ASB) is common in pregnancy and is associated
with higher risks of symptomatic cystitis, ascending pyelonephritis,
and preterm delivery [10,11]. In contrast, associations between
ASB and UTI in non-pregnant individuals appear to be more
complex, in some cases even showing a protective effect of ASB
[12,13,14,15]. Other studies have correlated increased parity
(number of gestations) and advanced age with a greater risk of
UTI [1,7]. Indeed, pregnant women and the elderly suffer a
greater risk of complicated UTI and other adverse outcomes, such
as pyelonephritis, bacteremia, and urosepsis [16,17,18]. In
addition to the influence of parity, UTI rates and bacterial
etiologies differ between younger and older populations [1,18].
Despite the unique risks of UTI to women at particular life stages,
in vivo models of UTI almost exclusively study this infection in
young nulliparous animals.
Here we examine the impact of age and parity on host
susceptibility to acute and chronic UTI across a range of ages and
prior reproductive experiences. We use a well-characterized
murine model of UTI in female C3H/HeN mice, which have
been extensively used for studies of acute and chronic UTI
[4,19,20,21,22,23,24,25]. UPEC colonization in this model follows
a reproducible cascade of intracellular and extracellular bladder
colonization events during the first 24 hours of acute infection
[25,26]. Thereafter, a subset of UPEC-infected animals experience
persistent bacteriuria throughout their lifetime, displaying .104
CFU bacteria in the bladder and per milliliter of urine [19]. We
characterized infection dynamics for UPEC and GBS, and
examined whether GBS modifies susceptibility to UPEC infection,
PLOS ONE | www.plosone.org 1 May 2014 | Volume 9 | Issue 5 | e97798
as we have recently reported in young nulliparous mice [3]. In that
study, we examined the consequence of multi-species inoculation
into the urinary tract, because UTI in humans often proceeds from
exposure to inherently polymicrobial bacterial community derived
from the gut and/or periurethral area. We showed that GBS
presence along with UPEC at the time of inoculation significantly
altered acute and chronic UPEC UTI outcomes, despite the fact
that GBS was rapidly cleared from the urinary tract within the first
24 hours after infection [3]. This previous study suggests that, in
humans, GBS may not be at detectable titers at the time a
symptomatic individual visits the clinic despite being present at the
time of infection.
Here we extend those studies and show that in virgin
nulliparous mice, increased age is associated with less severe
monomicrobial or polymicrobial acute UTI, in each case
characterized by ,100-fold lower UPEC titers in old vs. young
mice. On the other hand, among older mice, multiparity was
associated with greater susceptibility to severe high titer acute and
chronic UTI. Evidence is presented that this parity-associated
augmentation of UTI requires intact inflammatory processes
initiated through the microbe-associated pattern receptor TLR4.
Materials and Methods
Ethics Statement
All animal experiments were conducted following the National
Institutes of Health guidelines for housing and care of laboratory
animals and in accordance with institutional regulations and
approval by the Committee for Animal Studies at Washington
University School of Medicine. During the course of experiments,
animal pain and distress was minimized by: performing infections
while mice were under isoflurane anesthetic, monitoring them
until recovery from isofluorane, and checking the animals again 1–
4 hours after infection. Uropathogenic microorganisms do not
typically cause severely painful symptoms; nevertheless, mice were
closely monitored for signs of pain, distress, or dehydration. While
not necessary during our studies, analgesic administration or
injectable saline administration via intra peritoneal injection could
have been applied for pain or dehydration as needed. At the end of
experiments, animals were euthanized by cervical dislocation
while under isoflurane anesthetic.
Bacterial Strains and Growth Conditions
Uropathogenic E. coli strain UTI89 [27] or UTI89 attHK022::-
COM-GFP (kanamycin-resistant, KanR) [28] were inoculated from
single colonies grown on LB agar plates into LB containing
kanamycin at 25ug/ml where appropriate, and grown statically
overnight [18–24 hours (h)] at 37uC as described for infection
studies [25,29,30,31] to promote expression of type 1 pili
important for bladder infection [32,33]. Streptococcus agalactiae
(GBS) wild type strain COH1, a well-characterized strain that
expresses low levels of the beta-hemolysin and high levels of the
capsular polysaccharide [34,35,36,37] were inoculated from single
colonies grown on Todd Hewitt (TH) agar into TH broth (Difco).
GBS were grown statically overnight, and then diluted 1:10 in
fresh TH broth for an additional 1 to 2 h at 37uC to an optical
density at 600 nm (OD600) of approximately 0.4 (logarithmic
phase) as previously described for GBS UTI and other in vivo
virulence studies [3,4,5,38].
Murine Infections
Bacterial cultures, grown as described above, were collected by
centrifugation and resuspended in phosphate-buffered saline
(PBS). Female wild-type nulliparous mice aged 7–10 weeks or 8–
9 months, or retired breeders (multiparous) ranging from 7–11
months of age were obtained from Harlan (C3H/HeN) or the
Jackson Laboratories (C3H/HeJ). Mice were anesthetized by
inhalation of 4% isoflurane. Mice were then voided prior to
transurethral bacterial inoculation with 1–26107 CFU in 50 mL
[39]. For mixed infections, GBS and UPEC were mixed to obtain
a 50 mL bacterial suspension of 1–26107 CFU of each organism.
At indicated time points, mice were euthanized and bladders and
kidneys were aseptically removed. The number of bacteria present
in the tissues was determined by homogenization of bladders or
kidney pairs in PBS and plating of serial dilutions on LB or TH
agar supplemented with antibiotics when appropriate. For
comparisons of infection in differently aged animals, organ weights
of uninfected 7–11 week nulliparous or 8–9 month multiparous
animals were measured and used for CFU/g calculations. While
most published studies use CFU/organ, we noticed that older mice
had significantly larger organs than younger animals. The weight
normalization between younger and older mice thus allowed a
reduction of the impact of this potential bias on our interpreta-
tions. Statistical analyses were performed using the Kruskal-Wallis
test with Dunn’s post-test for multiple comparisons where p,0.05
was considered significant with GraphPad Prism software (version
6.00 for Windows, GraphPad Software, www.graphpad.com).
Recovered titers of zero were set to the limit of detection of the
assay of 40 CFU/organ, and also adjusted for organ weight for
comparisons of animals of different ages where appropriate, prior
to statistical analyses and graphical representation.
Results
Age and Parity are Inversely-related Factors Influencing
Acute Cystitis and Ascending Pyelonephritis
To evaluate the impact of age, (independent of parity), female
mice ranging in age between 7–9 weeks or 7–11 months that had
never been bred or given birth (nulliparous virgin) were
transurethrally infected with either UPEC or GBS or both. These
experiments showed that young nulliparous mice experienced
more severe acute cystitis compared to aged nulliparous mice at 24
hours post infection (hpi) (,100-fold higher bladder titers of
UPEC and ,15-fold higher GBS titers in young vs. aged
nulliparous mice) (Fig. 1A–B). Younger nulliparous animals also
exhibited nearly 1000-fold higher titers of UPEC than aged virgins
in the bladder and ,8-fold higher titers in the kidneys following
simultaneous infection with both UPEC and GBS (Fig. 1A&C).
As described above, bacterial titers in acute GBS cystitis were
lower in aged versus young nulliparous virgins (Fig. 1B). In
contrast, GBS kidney infection was equally robust in older versus
younger virgins with approximately 105 GBS recovered from the
kidneys in female mice of all ages (Fig. 1D). UPEC titers were
similar in the presence or absence of GBS (Fig. 1A&C) whereas,
consistent with our previous findings in young mice where we
observed that GBS were rapidly cleared after co-infection with
UPEC [3], GBS were rapidly cleared when UPEC were also
present in the inoculum (Fig. 1B&D). CFU/organ data, prior to
adjustment for age-associated difference in organ weights, are
shown in Fig. S1. In summary, these data indicate that, when
controlling for parity, increased age was associated with reduced
severity of cystitis in general and reduced severity of UPEC
pyelonephritis, whereas the severity of GBS pyelonephritis
remained constant with increasing age.
In humans, increasing age is often associated with increasing
reproductive experience. Hence, the observations that increased
age was associated with decreased UTI severity in Fig. 1A–D
were unexpected. To further examine the contribution of parity to
Age and Parity Effects on UTI Susceptibility
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UTI susceptibility, we compared age-matched nulliparous and
multiparous female mice for their susceptibility to UTI. Aged (7–
11month old) animals with or without reproductive experience
were infected with UPEC, GBS, or co-infected with UPEC+GBS.
While there was no significant impact of parity on susceptibility of
aged mice to monomicrobial UPEC infection, multiparous mice
that were co-infected exhibited nearly 2500-fold higher titers of
UPEC in the bladder, and ,8-fold higher titers of UPEC in the
kidney, compared to age-matched nulliparous mice (Fig. 2A–B;
note that the same 7–11 mo nulliparous data are plotted in Figs. 1
and 2 for ease of comparison with data from aged multiparous
hosts). Multiparity was also associated with significantly higher
GBS CFU in the bladders during GBS mono-species infection
(Fig. 2C–D). GBS CFU were significantly lower after co-infection
with UPEC, compared to GBS mono-infection, albeit only in
multiparous mice (Fig. 2C–D). Hence, the effects of parity on
GBS titers that we observed following mono-species UTI were not
detectable in the presence of UPEC.
Together these observations demonstrate that 1) among
nulliparous virgin mice, increased age rendered animals less
susceptible to acute UTI, and 2) in aged mice, multiparity
dramatically increased susceptibility to acute high titer cystitis,
particularly in the setting of polymicrobial UTI.
Multi-parity-augmented UPEC Bladder Infection is TLR4-
dependent
Previous studies have shown that TLR4 signaling is required to
mount a host response that limits UPEC infection in the bladder
[22,40,41,42,43]. C3H/HeJ mice are unable to mount a TLR4-
driven response [44,45] and exhibit higher titer acute bladder and
kidney infections compared to their TLR4 nonresponsive C3H/
HeJ counterparts [46]. To examine the contribution of TLR4
signaling in multiparity-augmented UTI, we infected 7–11 month
old multiparous C3H/HeJ or C3H/HeN mice with UPEC or with
UPEC+GBS and enumerated the CFU in bladders and kidneys at
24 hpi. As described in Fig. 2A, multiparous C3H/HeN mice
exhibited ,2500-fold higher titer UPEC cystitis (median
1.256108 CFU) following dual-species infection compared to
their nulliparous counterparts. Surprisingly, after the same dual-
species infection in multiparous C3H/HeJ mice, bladder titers
Figure 1. Age-associated risk factors for UTI in nulliparous virgin hosts. Organ weight-adjusted bladder CFU for UPEC (A) and GBS (B), and
kidney CFU for UPEC (C) and GBS (D) at 24 hours post infection of C3H/HeN female mice with ,107 UPEC UTI89 alone or with ,107 GBS COH1 in
UPEC+GBS mixed inoculation. N = 1–4, at least 5 mice per experiment, where N indicates the number of biologically distinct experiments performed
(N= 4 for 7–9wk groups, N = 1 for UPEC mono-infected 7–11mo group, and N= 2 for GBS mono-infected and all dual-infected 7–11mo groups).
Recovered titers of zero were set to the limit of detection of the assay for statistical analyses and graphical representation in all figures. The horizontal
bar represents the median value for each group of mice. Statistical significance was determined by the Kruskal-Wallis test with Dunn’s post-test for
multiple comparisons. * P,0.05, ** P,0.005, *** P,0.0005.
doi:10.1371/journal.pone.0097798.g001
Age and Parity Effects on UTI Susceptibility
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were nearly 50-fold lower than in age-matched C3H/HeN mice
(Fig. 3A). We also observed significantly higher titer cystitis after
mono-species UPEC infections in C3H/HeN mice compared to
C3H/HeJ mice (Fig. 3A). In contrast, aged C3H/HeJ mice had
significantly higher titer kidney infections after mono- or dual-
species UPEC infections (Fig. 3B). These results show that the
augmentation of bladder infection in multiparous mice is limited in
the absence of TLR4 signaling, strongly suggesting that TLR4-
driven inflammation is required for parity-associated susceptibility
to severe high titer acute cystitis but not pyelonephritis.
Multiparity Significantly Increases Susceptibility to
Chronic UPEC Infection
We have previously shown that the presence of UPEC and GBS
together at the time of urinary tract inoculation rendered young,
nulliparous mice significantly more likely to develop chronic
bladder infection [3]. Since multiparity was associated with higher
UPEC titers during acute UTI, we hypothesized that chronic
infection outcomes may be similarly impacted. To test this
hypothesis, we infected older (7–11mo) nulli- and multiparous
mice with UPEC alone or UPEC+GBS in a dual species
inoculation and measured CFUs in bladders and kidneys at 4
weeks post-infection. Similar to the results of acute UTI,
multiparous animals were dramatically more susceptible to chronic
cystitis, harboring ,8000-fold more UPEC CFU in the bladder
after single species infection (albeit not statistically significant) and
,900-fold higher after dual-species infection, compared to
nulliparous mice (Fig. 4A). In the kidneys, median UPEC CFU
after mono- or dual- species infection were at or below the limit of
detection in older nulliparous mice at 4 weeks post infection (wpi),
but were ,106 and ,104 in multiparous mice, respectively
(Fig. 4B). High UPEC titer (.104 CFU) in the bladder at 4 wpi
is a hallmark of chronic cystitis characterized by high bacterial
load in the bladder lumen [19]. The frequency of chronic cystitis
(i.e. mice with bladder titers .104 CFU/mL) was significantly
higher in multiparous mice after both mono- and dual-species
infection (,80% vs 20% and 60% vs. 10%, respectively, Fig. 4C).
We previously showed that GBS is cleared from the bladder of
young mice within 2 weeks post infection, but could persist in the
kidney in most animals [4]. The current data now demonstrates
Figure 2. Parity-associated risk factors for UTI in aged hosts. Bladder CFU for UPEC (A) and GBS (C), and kidney CFU for UPEC (B) and GBS (D)
at 24 hours post infection of C3H/HeN female mice with,107 UPEC UTI89 alone or with,107 GBS COH1 in UPEC+GBS mixed inoculation. N= 1–4, at
least 5 mice per experiment, as described for Fig. 1. Data from 7–11 mo (aged) nulliparous animals are replotted from Fig. 1 here for ease of
comparison with data from aged multiparous hosts. The horizontal bar represents the median value for each group of mice. Statistical significance
was determined by the Kruskal-Wallis test with Dunn’s post-test for multiple comparisons. * P,0.05, *** P,0.0005.
doi:10.1371/journal.pone.0097798.g002
Age and Parity Effects on UTI Susceptibility
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that most aged mice (irrespective of parity) cannot clear GBS
infections from the bladder or kidney (Fig. 4D–E).
In summary, we demonstrate that aged multiparous mice
exhibit heightened susceptibility to 1) acute high titer GBS cystitis
and pyelonephritis, 2) acute high titer UPEC cystitis and
pyelonephritis in the context of a polymicrobial exposure
containing GBS, and 3) chronic high titer UPEC infection in
the presence or absence of GBS.
Discussion
UTI is a significant public health problem that can affect
persons in all age groups; however, host susceptibility to severe,
chronic, recurrent, or complicated UTI, as well as the bacterial
uropathogen(s) causing UTI, varies over the female lifespan. Our
understanding of UTI susceptibility at different life stages is
limited, and progress is hampered by a lack of relevant model
systems. Here we model UTI susceptibility across a portion of the
female lifespan, examining acute and chronic UTI outcomes as a
function of bacterial etiology, age, and prior reproductive
experience.
Advanced age is associated with an increased risk of a variety of
infections in humans, including acute mono-species and polymi-
crobial UTI [8,18,47,48]. UTI in older adults is attributed to
many interrelated factors that include deteriorating immune
function, diminished integrity of anatomical barriers, exacerbating
underlying medical conditions, altered sex hormone levels, and
changes in vaginal microbial ecology [6,49,50]. For example, post-
menopausal women experience more recurrent chronic UTI than
their pre-menopausal counterparts, and lack of estrogen is thought
to contribute to this increased susceptibility [51,52,53]. However,
there are conflicting reports regarding the effect of estrogen
therapy on UTI susceptibility in this context [54,55,56,57]. Similar
to the human studies, findings in a murine model of surgical
menopause are also conflicting. Several studies show that
ovariectomized mice exhibited higher bacterial titers during acute
cystitis or more severe bladder symptoms [58,59], and estrogen
supplementation of ovariectomized animals limited some UTI-
associated symptoms [59]. However another study showed that
estrogen treatment resulted in an increased bacterial load in the
kidneys [60]. In vitro studies showing that estradiol exposure
simultaneously improves antimicrobial innate responses and
enhances bacterial invasion into urothelial cells may, in part,
explain differential effects of estrogen on UTI and discrepancies
observed in vivo [58].
Among older women, parity has been reported as a risk-factor
for UTI in some [7], but not all [61] studies. It is unclear whether
many studies with negative results were adequately powered to
examine parity-related differences since there are far fewer older
nulliparous than multiparous women in most populations. Further,
there are some reports of a positive correlation between pregnancy
and long-term hormonal effects [62]. For example, one study
measuring hormone levels at midcycle and luteal phases of the
menstrual cycle in premenopausal women showed increased
estradiol levels with increasing age in parous women, while
observing reduced estradiol levels with increasing age in nonpar-
ous women. [63]. Clearly, the relationships of estradiol levels to
age and parity are complex, but this may help to explain the
differential host susceptibility to urogenital infection.
Gestation and childbirth are also associated with numerous
functional and morphological changes to the urinary tract that
may impact UTI susceptibility, including incontinence and genital
prolapse [64,65]. Urine retention is thought to contribute to
enhanced UTI susceptibility among elderly and catheterized
individuals by limiting bacterial elimination from the bladder and
providing a reservoir in which bacteria can proliferate. These
physiologic changes have been modeled in rats, where multiparous
animals exhibited significantly increased bladder capacity and
residual urine volume in the bladder, compared to age-matched
nulliparous rats [65,66].
Surprisingly, and contrary to our initial hypothesis, we found
that older nulliparous mice were less susceptible to UPEC, GBS,
and polymicrobial UTI than were young nulliparous mice. We
show that multiparity, rather than increased age rendered C3H/
HeN mice more susceptible to acute high titer infections of the
bladder (GBS, and UPEC in the presence of GBS), suggesting that
the presence of GBS within a polymicrobial inoculum can
exacerbate acute UTI outcomes in this context. Based on this
finding, future clinical studies should examine GBS as a potential
risk factor for acute UPEC UTI in susceptible populations such as
Figure 3. Multiparity-associated augmentation of UPEC cystitis is blunted in C3H/HeJ mice. UPEC CFU in bladders (A) and kidneys (B)
were determined 24 hours after mono- or dual-species infection in 7–11 month old multiparous C3H/HeN and C3H/HeJ mice. N= 2–4, at least 5 mice
per experiment. The horizontal bar represents the median value for each group of mice. Statistical significance was determined by the Kruskal-Wallis
test with Dunn’s post-test for multiple comparisons. * P,0.05, ** P,0.005.
doi:10.1371/journal.pone.0097798.g003
Age and Parity Effects on UTI Susceptibility
PLOS ONE | www.plosone.org 5 May 2014 | Volume 9 | Issue 5 | e97798
pregnant and multiparous elderly women. We also show that
parity-associated increased severity of UPEC cystitis was aided by
TLR4- signaling in the bladder but not the kidney, since C3H/
HeJ mice deficient for TLR4-signaling have less severe cystitis.
These data suggest that bladder inflammation specifically
enhances UTI in older multiparous mice and we speculate that
the UPEC pathogenic cascade within the bladder, and the
contribution of inflammation, is significantly different in older
multiparous hosts. Further, multiparity significantly enhanced the
frequency of UPEC chronic cystitis (in the presence or absence of
GBS), which was often accompanied by chronic high titer
pyelonephritis. Overall these data firmly establish that multiparity
increases susceptibility to UTI in the C3H/HeN model. Further
studies are required, including an analysis of sex hormones in the
aged nulli- versus multi-parous mice, to clarify if this model can be
used to model infection human menopause. These findings also
call for further experiments to determine the reason underlying
increased susceptibility to UTI in multiparous animals, including
parameters of host immune response, and how this may translate
into an improved understanding of UTI susceptibility in older at-
risk women.
Supporting Information
Figure S1 Age-associated risk factors for UTI in nullip-
arous virgin hosts. Raw data corresponding to Figure 1, in
CFU/organ, are shown.
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